Cannabinoid Testing

The cannabinoid market is evolving fast, and regulatory requirements are tightening. Whether you're selling CBD products, supplying medical cannabis, or working toward Novel Food authorisation, we give you accurate, defensible results you can act on.

What we test and why it matters

Cannabinoid analysis isn't straightforward. The matrix you're working with, the concentration levels you're targeting, and the regulatory threshold you're trying to meet will all influence which method is right. We work with you to identify the right approach — not just run the test.

UKAS-accredited methods

Most of our cannabinoid tests are covered under our UKAS 17025 accreditation — giving you results that are accepted by regulators without question.

Multiple analytical platforms

From HPLC-UV for routine CBD profiling to LC-MS/MS, GC-MS/MS and qNMR for complex or low-level quantification — we match the method to the matrix.

Low level detection

Where low-level detection matters our GC-MS/MS and LC-MS/MS methods can go significantly further than conventional HPLC-UV detection.

Contaminant testing included

We cover the full picture: cannabinoid profiling, pesticides, PAHs, heavy metals, mycotoxins, residual solvents and terpene profiles.

Advice, not just results

Our scientists understand the regulatory context. We'll help you interpret what you're seeing and what to do next.

]

Which testing method do you need?

Choosing the wrong method can lead to inaccurate results - and that has consequences whether you're above a regulatory threshold or below it.

Connect with our specialists to find tailored solutions

Get in touch

Latest insights from Fera